SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-15-079983
Filing Date
2015-11-18
Accepted
2015-11-18 17:12:16
Documents
6
Effectiveness Date
2015-11-18

Document Format Files

Seq Description Document Type Size
1 S-8 a15-22763_1s8.htm S-8 118428
2 EX-5.1 a15-22763_1ex5d1.htm EX-5.1 68502
3 EX-5.2 a15-22763_1ex5d2.htm EX-5.2 69284
4 EX-23.3 a15-22763_1ex23d3.htm EX-23.3 3824
5 GRAPHIC g227631lci001.gif GRAPHIC 4414
6 GRAPHIC g227631lai001.gif GRAPHIC 4414
  Complete submission text file 0001104659-15-079983.txt   273439
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-208097 | Film No.: 151241532
SIC: 2834 Pharmaceutical Preparations